Effect of Infant and Maternal Secretor Status on Rotavirus Vaccine Take-An Overview.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
14 06 2021
Historique:
received: 04 05 2021
revised: 10 06 2021
accepted: 11 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 19 1 2022
Statut: epublish

Résumé

Histo-blood group antigens, which are present on gut epithelial surfaces, function as receptors or attachment factors and mediate susceptibility to rotavirus infection. The major determinant for susceptibility is a functional FUT2 enzyme which mediates the presence of α-1,2 fucosylated blood group antigens in mucosa and secretions, yielding the secretor-positive phenotype. Secretors are more susceptible to infection with predominant rotavirus genotypes, as well as to the commonly used live rotavirus vaccines. Difference in susceptibility to the vaccines is one proposed factor for the varying degree of efficacy observed between countries. Besides infection susceptibility, secretor status has been found to modulate rotavirus specific antibody levels in adults, as well as composition of breastmilk in mothers and microbiota of the infant, which are other proposed factors affecting rotavirus vaccine take. Here, the known and possible effects of secretor status in both infant and mother on rotavirus vaccine take are reviewed and discussed.

Identifiants

pubmed: 34198720
pii: v13061144
doi: 10.3390/v13061144
pmc: PMC8232156
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Blood Group Antigens 0
Rotavirus Vaccines 0
Fucosyltransferases EC 2.4.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Références

Vaccine. 2014 Feb 3;32(6):651-6
pubmed: 24374502
J Infect Dis. 2020 Mar 11;:
pubmed: 32157282
Trends Microbiol. 2013 Apr;21(4):167-73
pubmed: 23332725
Pediatr Infect Dis J. 2013 Aug;32(8):863-70
pubmed: 23584581
Glycobiology. 2004 Mar;14(3):253-63
pubmed: 14638628
J Infect Dis. 2019 Feb 15;219(5):746-749
pubmed: 30357332
Microbiome. 2015 Apr 10;3:13
pubmed: 25922665
Hum Vaccin Immunother. 2021 Apr 3;17(4):1223-1234
pubmed: 33121329
Sci Rep. 2020 May 8;10(1):7753
pubmed: 32385405
Pathogens. 2017 Dec 12;6(4):
pubmed: 29231855
Vaccine. 2014 Aug 11;32 Suppl 1:A134-9
pubmed: 25091668
Pediatr Infect Dis J. 2014 Jan;33 Suppl 1:S76-84
pubmed: 24343619
Nutrients. 2018 Oct 20;10(10):
pubmed: 30347801
Sci Rep. 2016 Oct 06;6:34591
pubmed: 27708367
mSystems. 2018 Dec 26;3(6):
pubmed: 30637338
J Infect Dis. 2020 Aug 4;222(5):836-839
pubmed: 32188998
Clin Infect Dis. 2016 May 1;62 Suppl 2:S96-S105
pubmed: 27059362
PLoS Pathog. 2019 Jun 21;15(6):e1007865
pubmed: 31226167
J Pediatr Gastroenterol Nutr. 2019 Feb;68(2):256-263
pubmed: 30540710
Open Biol. 2019 Sep 27;9(9):190128
pubmed: 31506017
Clin Infect Dis. 2019 Sep 27;69(8):1313-1319
pubmed: 30561537
Nat Genet. 2016 Nov;48(11):1396-1406
pubmed: 27723756
J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):825-33
pubmed: 25651488
J Infect Dis. 2020 Mar 16;221(7):1070-1078
pubmed: 31763671
Am J Clin Nutr. 2017 May;105(5):1086-1100
pubmed: 28356278
J Infect Dis. 2014 Jul 15;210(2):171-82
pubmed: 24436449
Sci Rep. 2018 Jan 24;8(1):1502
pubmed: 29367698
Sci Rep. 2018 Sep 13;8(1):13757
pubmed: 30214024
Nat Genet. 2021 Feb;53(2):147-155
pubmed: 33462482
J Infect Dis. 2015 Jun 1;211(11):1813-21
pubmed: 25505295
Nutr Rev. 2013 Dec;71(12):773-89
pubmed: 24246032
Gut Microbes. 2018 Mar 4;9(2):93-101
pubmed: 28891751
Transfusion. 1999 Sep;39(9):1013-7
pubmed: 10533829
Clin Diagn Lab Immunol. 2004 Jan;11(1):186-94
pubmed: 14715567
PLoS One. 2020 Nov 10;15(11):e0240714
pubmed: 33170860
J Nutr. 2017 Sep;147(9):1709-1714
pubmed: 28637685
Vaccine. 2018 Jan 4;36(2):273-279
pubmed: 28874323
Sci Rep. 2017 Mar 30;7:45559
pubmed: 28358023
BMC Microbiol. 2012 Jun 06;12:94
pubmed: 22672382
Nat Genet. 2016 Nov;48(11):1413-1417
pubmed: 27694960
Vaccine. 2018 Jan 4;36(2):264-272
pubmed: 29217369
Cell Mol Gastroenterol Hepatol. 2016 Mar 12;2(3):263-273
pubmed: 28090561
Pediatr Infect Dis J. 2010 Oct;29(10):919-23
pubmed: 20442687
Pathogens. 2021 Apr 26;10(5):
pubmed: 33925924
Viruses. 2019 Mar 06;11(3):
pubmed: 30845670
Sci Rep. 2020 Apr 24;10(1):6965
pubmed: 32332841
Physiol Genomics. 2017 Sep 1;49(9):473-483
pubmed: 28710295
Clin Vaccine Immunol. 2017 Jan 5;24(1):
pubmed: 27847365
BMC Genomics. 2016 Nov 21;17(1):941
pubmed: 27871240
Sci Rep. 2018 Aug 28;8(1):12961
pubmed: 30154494
Viruses. 2020 Sep 25;12(10):
pubmed: 32992989
PLoS One. 2015 Jun 02;10(6):e0127622
pubmed: 26035743
JAMA Pediatr. 2015 Nov;169(11):1040-5
pubmed: 26389824
Lancet Infect Dis. 2019 Jul;19(7):717-727
pubmed: 31178289
J Nutr. 2017 Jan;147(1):117-124
pubmed: 27798342
Infect Genet Evol. 2014 Dec;28:446-61
pubmed: 25224179
PLoS Pathog. 2020 Nov 19;16(11):e1009010
pubmed: 33211756
Curr Opin Virol. 2019 Aug;37:58-62
pubmed: 31284078
J Virol. 2012 Sep;86(18):9899-910
pubmed: 22761376
J Infect Dis. 2010 Sep 1;202 Suppl:S34-42
pubmed: 20684715
PLoS One. 2014 Apr 14;9(4):e94863
pubmed: 24733310
Virus Res. 2016 Jan 4;211:64-8
pubmed: 26454189
J Infect Dis. 2018 Apr 11;217(9):1399-1407
pubmed: 29390150
Viruses. 2020 Mar 17;12(3):
pubmed: 32192193
Gut Microbes. 2018 Jul 4;9(4):357-368
pubmed: 29533703
Viruses. 2018 Feb 24;10(2):
pubmed: 29495275
Nat Commun. 2018 Nov 27;9(1):5010
pubmed: 30479342
J Infect Dis. 2017 Mar 1;215(5):786-789
pubmed: 28329092
Sci Rep. 2019 Jul 24;9(1):10764
pubmed: 31341254
Am J Trop Med Hyg. 2020 Jan;102(1):213-219
pubmed: 31802728
Vaccine. 2020 Dec 3;38(51):8161-8166
pubmed: 33162202
Vaccine. 2018 Jun 7;36(24):3427-3433
pubmed: 29752022
Vaccine. 2020 Dec 14;38(52):8260-8263
pubmed: 33213928
Clin Infect Dis. 2014 Dec 1;59(11):1567-73
pubmed: 25097083
PLoS Pathog. 2016 Apr 26;12(4):e1005385
pubmed: 27115484
Hum Genet. 2020 Jun;139(6-7):903-910
pubmed: 31760489
J Infect Dis. 2017 Jan 1;215(1):34-41
pubmed: 27803175

Auteurs

Sumit Sharma (S)

Division of Molecular Medicine and Virology, Department of Clinical and Biomedical Sciences, Linköping University, 58183 Linköping, Sweden.

Johan Nordgren (J)

Division of Molecular Medicine and Virology, Department of Clinical and Biomedical Sciences, Linköping University, 58183 Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH